Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 9 (September)

1. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.
   Pediatrics, 118(3): 882-7. [Abstract] [Full-text]
2. Trends in sunburns, sun protection practices, and attitudes toward sun exposure protection and tanning among US adolescents, 1998-2004.
   Pediatrics, 118(3): 853-64. [Abstract] [Full-text]
3. Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature.
   Pediatrics, 118(3): e907-13. [Abstract] [Full-text]
4. Cutaneous lipoma in children: 5 cases with Bannayan-Riley-Ruvalcaba syndrome.
   J Pediatr Surg, 41(9): 1601-3. [Abstract] [Full-text]
5. Mutations in DNA polymerase eta are not detected in squamous cell carcinoma of the skin.
   Int J Cancer, 119(9): 2225-7. [Abstract] [Full-text]
6. Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
   Oncogene, 25(40): 5507-16. [Abstract] [Full-text]
7. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis.
   Am J Hum Genet, 79(4): 759-64. [Abstract] [Full-text]
8. Somatic activation of KIT in distinct subtypes of melanoma.
   J Clin Oncol, 24(26): 4340-6. [Abstract] [Full-text]
9. Cutaneous squamous cell carcinoma metastatic to chronic lymphocytic leukaemia: diagnostic potential of fine needle aspiration cytology.
   Cytopathology, 17(5): 288-94. [Abstract] [Full-text]
10. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
    Eur J Haematol, 77(4): 300-3. [Abstract] [Full-text]
11. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.
    J Clin Oncol, 24(27): 4464-71. [Abstract] [Full-text]
12. Sebaceous skin lesions as clues to hereditary non-polyposis colorectal cancer.
    J Invest Dermatol, 126(10): 2158-9. [Abstract] [Full-text]
13. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
    J Invest Dermatol, 126(10): 2302-7. [Abstract] [Full-text]
14. Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.
    J Invest Dermatol, 126(10): 2217-23. [Abstract] [Full-text]
15. Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization.
    J Invest Dermatol, 126(10): 2308-15. [Abstract] [Full-text]
16. The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma.
    J Invest Dermatol, 126(10): 2242-6. [Abstract] [Full-text]
17. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Cancer, 107(6): 1331-9. [Abstract] [Full-text]
18. Assessment of carcinogenic potential of repeated fish fried oil in mice.
    Mol Carcinog, 45(10): 741-51. [Abstract] [Full-text]
19. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand.
    Hum Pathol, 37(10): 1286-94. [Abstract] [Full-text]
20. Pulmonary mycobacteriosis in a patient affected by mycosis fungoides: a diagnostic and therapeutic challenge.
    J Infect, 53(4): e181-3. [Abstract] [Full-text]
21. Sarcomatoid basal cell carcinoma--predilection for osteosarcomatous differentiation: a series of 11 cases.
    Am J Surg Pathol, 30(10): 1299-308. [Abstract] [Full-text]
22. Ethnic differences among patients with cutaneous melanoma.
    Arch Intern Med, 166(17): 1907-14. [Abstract] [Full-text]
23. Sentinel-node biopsy or nodal observation in melanoma.
    N Engl J Med, 355(13): 1307-17. [Abstract] [Full-text]
24. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
    J Clin Oncol, 24(28): 4565-9. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.